Patents by Inventor Abu Serajuddin

Abu Serajuddin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Spontaneously Dispersible Pharmaceutical Composition
    Publication number: 20080064760
    Abstract: A spontaneously dispersible pharmaceutical composition comprising a poorly soluble drug and a carrier medium comprising (1) a lipophilic component, (2) a surfactant, and optionally (3) a hydrophilic component, wherein at least one of the components (1) to (3) is solid at room temperature. A particularly useful hydrophilic component in the system is a polymer that is solid at room temperature, e.g., solid PEG.
    Type: Application
    Filed: October 27, 2005
    Publication date: March 13, 2008
    Inventors: Ping Li, Madhusudhan Pudipeddi, Alan Royce, Sara Hynes, Abu Serajuddin, Michael Ambuhl, Barbara Luckel
  • Fast Release Composition Including Melt Granules of a Moisture Sensitive Drug and Process for Manufacturing Thereof
    Publication number: 20080050443
    Abstract: Solid oral dosage forms that include melt granules of a moisture-sensitive therapeutic compound and a hydrophobic melt component. The melt granules better protect the therapeutic compound from hydrolytic degradation. Such solid oral dosage forms also possess immediate-release characteristics rather than that associated with extended-release or controlled-release drug products.
    Type: Application
    Filed: August 26, 2005
    Publication date: February 28, 2008
    Inventors: James Kowalski, Oskar Kalb, Abu Serajuddin, Yatindra Joshi
  • Pharmaceutical formulations of bisphosphonates
    Publication number: 20070134319
    Abstract: A pharmaceutical formulation comprising an oral dosage form containing a bisphosphonic acid or a salt thereof and an inactive ingredient selected from: an ester of a medium chain fatty acid, or a lipophilic polyethylene glycol ester, said inactive ingredient having a hydrophilic lipophilic balance (HLB) of from about 1 to about 30.
    Type: Application
    Filed: December 22, 2004
    Publication date: June 14, 2007
    Applicant: NOVARTIS AG
    Inventors: Erika Zannou, Simon Bateman, Madhusudhan Pudipeddi, Alan Royce, Abu Serajuddin